Comments
Loading...

ImmunoPrecise Antibodies

IPANASDAQ
Logo brought to you by Benzinga Data
$0.348400
-0.04-9.72%
At close: -
$0.345000
-0.0034-0.98%
After Hours: 5:30 PM EDT

ImmunoPrecise Antibodies (NASDAQ:IPA) Stock, Earnings Estimates, EPS, And Revenue

ImmunoPrecise Antibodies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Dec 12
EPS Estimate
$-0.070
Quarterly Revenue Estimate
$4.8M
Annual Revenue
(as of Jul 31)
$24.1M

Analyze the earnings history of ImmunoPrecise Antibodies using advanced sorting and filters.

Data brought to you by Benzinga APIs

ImmunoPrecise Antibodies (IPA) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-09-16$-0.11$-0.08-37.5 %
Jun 20242024-07-29$-0.58$-0.08-625.0 %
Dec 20232024-03-14$-0.08$-0.07-14.3 %
Sep 20232023-12-14$-0.07$-0.1026.0 %

ImmunoPrecise Antibodies (IPA) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20242024-09-16$3.87M$4.96M-22.0 %
Jun 20242024-07-29$4.72M$4.72M0.02 %
Dec 20232024-03-14$4.56M$4.50M1.22 %
Sep 20232023-12-14$4.62M$4.33M6.74 %

FAQ

Q

When is ImmunoPrecise Antibodies (NASDAQ:IPA) reporting earnings?

A

ImmunoPrecise Antibodies (IPA) is scheduled to report earnings on December 12, 2024. The last reported earnings were for reported on September 16, 2024 for Q1.

Q

What were the latest earnings per share (EPS) for ImmunoPrecise Antibodies (NASDAQ:IPA)?

A

The Actual EPS was $-0.11, which missed the estimate of $-0.08.

Q

What were ImmunoPrecise Antibodies’s (NASDAQ:IPA) revenues?

A

The Actual Revenue was $3.9M, which missed the estimate of $5M.

Browse earnings estimates, EPS, and revenue on all stocks.